11 Others have confirmed that GH action is lower in patients with MASH [12] including significantly lower levels of IGF-1, IGF-2, and the ratio of IGF-1 to IGFBP-3. Here, IGF2 is linked to metabolic dysfunction-associated steatohepatitis.